AB 647 Wisconsin Assembly · 2019-2020 Regular Session

Relating to: the prescription drug monitoring program. (FE)

Bill status signed all 5 stages cleared

Introduction

Dec 2019

Committee Review

Feb 2020

Assembly Passage

Feb 2020

Senate Passage

Feb 2020

Signed into Law

Mar 2020

Introduced Dec 5, 2019 Signed Mar 3, 2020

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 3, 2020

Signed into law

Report approved by the Governor on 3-3-2020. 2019 Wisconsin Act 121

lower

Feb 20, 2020

Lower · Passed

Received from Senate concurred in

lower

Feb 19, 2020

Upper · Passed

Read a third time and concurred in

upper

Feb 14, 2020

Upper · Passed

Public hearing requirement waived by committee on Senate Organization, pursuant to Senate Rule 18 (1m), Ayes 5, Noes 0

upper

Jan 27, 2020

Committee

Read first time and referred to committee on Senate Organization

upper

Jan 21, 2020

Lower · Passed

Read a third time and passed

lower

Jan 16, 2020

Lower · Passed

Placed on calendar 1-21-2020 by Committee on Rules

lower

Jan 16, 2020

Committee

Referred to committee on Rules

lower

Jan 16, 2020

Lower · Passed

Report passage recommended by Committee on Substance Abuse and Prevention, Ayes 9, Noes 0

lower

Dec 5, 2019

Committee

Read first time and referred to Committee on Substance Abuse and Prevention

lower

Dec 5, 2019

Introduced

Introduced by Representatives Nygren, Plumer, Magnafici, Hutton, James, Petryk, Kolste, Sargent, Billings, Born, Snyder, Petersen, Kitchens, Quinn, Felzkowski, Edming, Kulp, Rohrkaste, Knodl, Tusler, Duchow, Dittrich, Tranel, Thiesfeldt, Jagler, Spiros, Mursau, Ramthun, Pope, Doyle, Bowen and Spreitzer; cosponsored by Senators Testin, Cowles, Olsen, Wanggaard, Schachtner and Marklein

lower

28 primary · 0 co-sponsors